Cargando…
Blood-based biomarkers of inflammation in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disease in which many processes are detected including (neuro)inflammation. Many drugs have been tested for ALS in clinical trials but most have failed to reach their primary endpoints. The development and inclusion of different...
Autores principales: | Staats, Kim A., Borchelt, David R., Tansey, Malú Gámez, Wymer, James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785449/ https://www.ncbi.nlm.nih.gov/pubmed/35073950 http://dx.doi.org/10.1186/s13024-022-00515-1 |
Ejemplares similares
-
Blood Biomarkers for Amyotrophic Lateral Sclerosis: Myth or Reality?
por: Robelin, Laura, et al.
Publicado: (2014) -
Dextromethorphan/quinidine for the treatment of bulbar impairment in amyotrophic lateral sclerosis
por: Tabor Gray, Lauren, et al.
Publicado: (2023) -
Diagnostic utility of the amyotrophic lateral sclerosis Functional Rating Scale—Revised to detect pharyngeal dysphagia in individuals with amyotrophic lateral sclerosis
por: Chapin, Jennifer L., et al.
Publicado: (2020) -
Respiratory therapies for Amyotrophic Lateral Sclerosis: A state of
the art review
por: Sales de Campos, Priscila, et al.
Publicado: (2023) -
MicroRNAs as Biomarkers in Amyotrophic Lateral Sclerosis
por: Ricci, Claudia, et al.
Publicado: (2018)